Novel coronavirus infection (COVID-19) and kidney disease

Close metadata

Recommended articles:

Causes of hospital mortality in adults based on medical certificates of death. Russian Journal of Preventive Medicine. 2024;(3):7-13

Antibiotic resistance of the upper respiratory tract microbiota in children with the new coronavirus infection in Ryazan. Russian Journal of Preventive Medicine. 2024;(3):45-51

Variability of death rates from respiratory diseases in the regions of the Russian Federation during the COVID-19 pandemic and the three previous years. Russian Journal of Preventive Medicine. 2024;(4):82-88

A clinical case of the new-onset bipolar affective disorder in the postcovid period. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3):125-129

Comparison of the clinical performance of immunochromatographic tests for the detection of SARS-CoV-2 antigens with data from independent studies. Laboratory Service. 2024;(1):13-19

Adverse perinatal outcomes in COVID-19. Analysis of a series of clinical observations. Russian Bulletin of Obstetrician-Gynecologist. 2024;(2):86-90

Staging of COVID-19 morphological manifestations in lungs depending on disease duration. Forensic Medical Expertise. 2024;(2):28-31

Russian COVID-19 vaccines as a risk factor of myopericarditis in patients with or without previous infection. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(2):184-193

Exosomes’ role in intercellular interactions in different variants of lung injury in fatal cases of COVID-19. Russian Journal of Archive of Pathology. 2024;(2):22-29

Age features of immunity to SARS-CoV-2 of metropolis population in the dynamics. Russian Journal of Clinical Dermatology and Venereology. 2024;(2):118-128

The novel coronavirus infection (COVID-19), which began spreading in 2019, caused a pandemic in March 2020. Evidence to date indicates the importance of monitoring kidney function in patients with this infection, as the damage to kidney tissue in COVID-19 is associated with worse prognosis and high mortality. Respiratory failure, which often accompanies severe forms of the disease, is mutually aggravated by acute kidney injury, which complicates the management of such patients.

Keywords:

COVID-19

acute kidney injury

SARS-CoV-2

Authors:

Kravchenko A.Ya.

Burdenko Voronezh State Medical University of the Ministry of Health of Russia

Kontsevaya A.V.

National Medical Research Center for Therapy and Preventive Medicine

SPIN RSCI: 6787-2500
Scopus AuthorID: 55672262900
ORCID: 0000-0003-2062-1536

Budnevsky A.V.

N.N. Burdenko Voronezh State Medical University

Chernik T.A.

Burdenko Voronezh State Medical University of the Ministry of Health of Russia

Received:

11.11.2021

Accepted:

26.01.2022

List of references:

World Health Organization. Coronavirus Disease 2019 (COVID-19). Situation report — 51. Accessed December 09, 2021. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200311-sitrep-51-covid-19.pdf?sfvrsn=1ba62e57_10 (2020)
Johns Hopkins University, National Public Health Agencies. Figures Last Updated 23 August 2021, 07:44 BST. Accessed December 09, 2021. https://coronavirus.jhu.edu/
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. [Published correction appears in JAMA. 2020;325(11):1113]. JAMA. 2020;323(11):1061-1069. https://doi.org/10.1001/jama.2020.1585
Chu KH, Tsang WK, Tang CS, Lam MF, Lai FM, To KF, Fung KS, Tang HL, Yan WW, Chan HW, Lai TS, Tong KL, Lai KN. Acute renal impairment in coronavirus-associated severe acute respiratory syndrome. Kidney International. 2005;67(2):698-705. https://doi.org/10.1111/j.1523-1755.2005.67130.x
Eckerle I, Müller MA, Kallies S, Gotthardt DN, Drosten C. In-vitro renal epithelial cell infection reveals a viral kidney tropism as a potential mechanism for acute renal failure during Middle East Respiratory Syndrome (MERS) Coronavirus infection. Virology Journal. 2013;10:359. https://doi.org/10.1186/1743-422X-10-359
Su H, Yang M, Wan C, Yi LX, Tang F, Zhu HY, Yi F, Yang HC, Fogo AB, Nie X, Zhang C. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney International. 2020;98(1): 219-227. https://doi.org/10.1016/j.kint.2020.04.003
Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, Li J, Yao Y, Ge S, Xu G. Kidney impairment is associated with in-hospital death of COVID-19 patients. medRxiv Preprint. 2020. https://doi.org/10.1101/2020.02.18.20023242
Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, Li J, Yao Y, Ge S, Xu G. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney International. 2020;97(5):829-838. https://doi.org/10.1016/j.kint.2020.03.005
Teixeira JP, Ambruso S, Griffin BR, Faubel S. Pulmonary Consequences of Acute Kidney Injury. Seminars in Nephrology. 2019;39(1):3-16. https://doi.org/10.1016/j.semnephrol.2018.10.001
Chertow GM, Christiansen CL, Cleary PD, Munro C, Lazarus JM. Prognostic stratification in critically ill patients with acute renal failure requiring dialysis. Archives of Internal Medicine. 1995;155(14):1505-1511.
Faubel S, Edelstein CL. Mechanisms and mediators of lung injury after acute kidney injury. Nature Reviews. Nephrology. 2016;12(1):48-60. https://doi.org/10.1038/nrneph.2015.158
Koyner JL, Murray PT. Mechanical ventilation and the kidney. Blood Purification. 2010;29(1):52-68. https://doi.org/10.1159/000259585
Annat G, Viale JP, Bui Xuan B, Hadj Aissa O, Benzoni D, Vincent M, Gharib C, Motin J. Effect of PEEP ventilation on renal function, plasma renin, aldosterone, neurophysins and urinary ADH, and prostaglandins. Anesthesiology. 1983;58(2):136-141. https://doi.org/10.1097/00000542-198302000-00006
Andrivet P, Adnot S, Sanker S, Chabrier PE, Macquin-Mavier I, Braquet P, Brun-Buisson C. Hormonal interactions and renal function during mechanical ventilation and ANF infusion in humans. Journal of Applied Physiology. 1991;70(1):287-292. https://doi.org/10.1152/jappl.1991.70.1.287
Han X, Ye Q. Kidney involvement in COVID-19 and its treatments. Journal of Medical Virology. 2021;93(3):1387-1395. https://doi.org/10.1002/jmv.26653
Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, Chen HD, Chen J, Luo Y, Guo H, Jiang RD, Liu MQ, Chen Y, Shen XR, Wang X, Zheng XS, Zhao K, Chen QJ, Deng F, Liu LL, Yan B, Zhan FX, Wang YY, Xiao GF, Shi ZL. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270-273. https://doi.org/10.1038/s41586-020-2012-7
Mizuiri S, Ohashi Y. ACE and ACE2 in kidney disease. World Journal of Nephrology. 2015;4(1):74-82. https://doi.org/10.5527/wjn.v4.i1.74
Ahmadian E, Hosseiniyan Khatibi SM, Razi Soofiyani S, Abediazar S, Shoja MM, Ardalan M, Zununi Vahed S. Covid-19 and kidney injury: Pathophysiology and molecular mechanisms. Reviews in Medical Virology. 2021;31(3):e2176. https://doi.org/10.1002/rmv.2176
Radzikowska U, Ding M, Tan G, Zhakparov D, Peng Y, Wawrzyniak P, Wang M, Li S, Morita H, Altunbulakli C, Reiger M, Neumann AU, Lunjani N, Traidl-Hoffmann C, Nadeau KC, O’Mahony L, Akdis C, Sokolowska M. Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors. Allergy. 2020;75(11):2829-2845. https://doi.org/10.1111/all.14429
Wang K, Chen W, Zhang Z, Deng Y, Lian JQ, Du P, Wei D, Zhang Y, Sun XX, Gong L, Yang X, He L, Zhang L, Yang Z, Geng JJ, Chen R, Zhang H, Wang B, Zhu YM, Nan G, Jiang JL, Li L, Wu J, Lin P, Huang W, Xie L, Zheng ZH, Zhang K, Miao JL, Cui HY, Huang M, Zhang J, Fu L, Yang XM, Zhao Z, Sun S, Gu H, Wang Z, Wang CF, Lu Y, Liu YY, Wang QY, Bian H, Zhu P, Chen ZN. CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells. Signal Transduction and Targeted Therapy. 2020;5(1):283. https://doi.org/10.1038/s41392-020-00426-x
Farkash EA, Wilson AM, Jentzen JM. Ultrastructural Evidence for Direct Renal Infection with SARS-CoV-2 [published correction appears in J Am Soc Nephrol. 2020;31(10):2494]. Journal of the American Society of Nephrology: JASN. 2020;31(8):1683-1687. https://doi.org/10.1681/ASN.2020040432
Rossi GM, Delsante M, Pilato FP, Gnetti L, Gabrielli L, Rossini G, Re MC, Cenacchi G, Affanni P, Colucci ME, Picetti E, Rossi S, Parenti E, Maccari C, Greco P, Di Mario F, Maggiore U, Regolisti G, Kidney biopsy findings in a critically ill COVID-19 patient with dialysis-dependent acute kidney injury: a case against «SARS-CoV-2 nephropathy». Kidney International Reports. 2020;5(7):1100-1105. https://doi.org/10.1016/j.ekir.2020.05.005.
Santoriello D, Khairallah P, Bomback AS, Xu K, Kudose S, Batal I, Barasch J, Radhakrishnan J, D’Agati V, Markowitz G. Postmortem kidney pathology findings in patients with COVID-19. Journal of the American Society of Nephrology: JASN. 2020;31(9):2158-2167. https://doi.org/10.1681/ASN.2020050744
Diao B, Wang C, Wang R, Feng Z, Zhang J, Yang H, Tan Y, Wang H, Wang C, Liu L, Liu Y, Liu Y, Wang G, Yuan Z, Hou X, Ren L, Wu Y, Chen Y. Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection. Nature Communications. 2021;12(1):2506. https://doi.org/10.1038/s41467-021-22781-1
Larsen CP, Bourne TD, Wilson JD, Saqqa O, Sharshir MA. Collapsing glomerulopathy in a patient with coronavirus disease 2019 (COVID-19). Kidney International Reports. 2020;5(6):935-939. https://doi.org/10.1016/j.ekir.2020.04.002
Nadim MK, Forni LG, Mehta RL, Connor MJ Jr, Liu KD, Ostermann M, Rimmelé T, Zarbock A, Bell S, Bihorac A, Cantaluppi V, Hoste E, Husain-Syed F, Germain MJ, Goldstein SL, Gupta S, Joannidis M, Kashani K, Koyner JL, Legrand M, Lumlertgul N, Mohan S, Pannu N, Peng Z, Perez-Fernandez XL, Pickkers P, Prowle J, Reis T, Srisawat N, Tolwani A, Vijayan A, Villa G, Yang L, Ronco C, Kellum JA. COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup. Nature Reviews. Nephrology. 2020;16(12):747-764. https://doi.org/10.1038/s41581-020-00356-5
Hirsch JS, Ng JH, Ross DW, Sharma P, Shah HH, Barnett RL, Hazzan AD, Fishbane S, Jhaveri KD; Northwell COVID-19 Research Consortium; Northwell Nephrology COVID-19 Research Consortium. Acute kidney injury in patients hospitalized with COVID-19. Kidney International. 2020; 98(1):209-218. https://doi.org/10.1016/j.kint.2020.05.006
Sargiacomo C, Sotgia F, Lisanti MP. COVID-19 and chronological aging: senolytics and other anti-aging drugs for the treatment or prevention of corona virus infection? Aging. 2020;12(8):6511-6517. https://doi.org/10.18632/aging.103001
Devaux CA, Rolain JM, Raoult D. ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome. Journal of Microbiology, Immunology, and Infection. 2020; 53(3):425-435. https://doi.org/10.1016/j.jmii.2020.04.015
Kidney Disease Improving Global Outcomes, Acute Kidney Injury Work Group: KDIGO clinical practice guideline for acute kidney injury. Kidney International. 2012;2(suppl):1-138.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. https://doi.org/10.1016/S0140-6736(20)30183-5
Ng JH, Hirsch JS, Hazzan A, Wanchoo R, Shah HH, Malieckal DA, Ross DW, Sharma P, Sakhiya V, Fishbane S, Jhaveri KD; Northwell Nephrology COVID-19 Research Consortium. Outcomes Among Patients Hospitalized With COVID-19 and Acute Kidney Injury. American Journal of Kidney Diseases. 2021;77(2):204-215.e1. https://doi.org/j.ajkd.2020.09.002
Husain-Syed F, Wilhelm J, Kassoumeh S, Birk HW, Herold S, Vadász I, Walmrath HD, Kellum JA, Ronco C, Seeger W. Acute kidney injury and urinary biomarkers in hospitalized patients with coronavirus disease-2019. Nephrology, Dialysis, Transplantation. 2020;35(7):1271-1274. https://doi.org/10.1093/ndt/gfaa162
Clermont G, Acker CG, Angus DC, Sirio CA, Pinsky MR, Johnson JP. Renal failure in the ICU: comparison of the impact of acute renal failure and end-stage renal disease on ICU outcomes. Kidney International. 2002;62(3): 986-996. https://doi.org/10.1046/j.1523-1755.2002.00509.x
Henry BM, Lippi G. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection. International Urology and Nephrology. 2020;52(6):1193-1194. https://doi.org/10.1007/s11255-020-02451-9
Suleyman G, Fadel RA, Malette KM, Hammond C, Abdulla H, Entz A, Demertzis Z, Hanna Z, Failla A, Dagher C, Chaudhry Z, Vahia A, Abreu Lanfranco O, Ramesh M, Zervos MJ, Alangaden G, Miller J, Brar I. Clinical Characteristics and Morbidity Associated with Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit. JAMA Network Open. 2020; 3(6):e2012270. https://doi.org/10.1001/jamanetworkopen.2020.12270
Cohen-Hagai K, Rozenberg I, Korzets Z, Zitman-Gal T, Einbinder Y, Benchetrit S. Upper Respiratory Tract Infection among Dialysis Patients. The Israel Medical Association Journal: IMAJ. 2016;18(9):557-560.
Sibbel S, Sato R, Hunt A, Turenne W, Brunelli SM. The clinical and economic burden of pneumonia in patients enrolled in Medicare receiving dialysis: a retrospective, observational cohort study. BMC Nephrology. 2016; 17(1):199. https://doi.org/10.1186/s12882-016-0412-6
Sarnak MJ, Jaber BL. Pulmonary infectious mortality among patients with end-stage renal disease. Chest. 2001;120(6):1883-1887. https://doi.org/10.1378/chest.120.6.1883
Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX, Chong M, Lee M. Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. JAMA. 2020;323(16):1612-1614. https://doi.org/10.1001/jama.2020.4326
Keddissi JI, Youness HA, Jones KR, Kinasewitz GT. Fluid management in Acute Respiratory Distress Syndrome: A narrative review. Canadian Journal of Respiratory Therapy: CJRT. 2018;55:1-8. https://doi.org/10.29390/cjrt-2018-016
Argenziano MG, Bruce SL, Slater CL, Tiao JR, Baldwin MR, Barr RG, Chang BP, Chau KH, Choi JJ, Gavin N, Goyal P, Mills AM, Patel AA, Romney MS, Safford MM, Schluger NW, Sengupta S, Sobieszczyk ME, Zucker JE, Asadourian PA, Bell FM, Boyd R, Cohen MF, Colquhoun MI, Colville LA, de Jonge JH, Dershowitz LB, Dey SA, Eiseman KA, Girvin ZP, Goni DT, Harb AA, Herzik N, Householder S, Karaaslan LE, Lee H, Lieberman E, Ling A, Lu R, Shou AY, Sisti AC, Snow ZE, Sperring CP, Xiong Y, Zhou HW, Natarajan K, Hripcsak G, Chen R. Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series. BMJ. 2020;369:m1996. https://doi.org/10.1136/bmj.m1996
Grein J, Ohmagari N, Shin D, Diaz G, Asperges E, Castagna A, Feldt T, Green G, Green ML, Lescure FX, Nicastri E, Oda R, Yo K, Quiros-Roldan E, Studemeister A, Redinski J, Ahmed S, Bernett J, Chelliah D, Chen D, Chihara S, Cohen SH, Cunningham J, D’Arminio Monforte A, Ismail S, Kato H, Lapadula G, L’Her E, Maeno T, Majumder S, Massari M, Mora-Rillo M, Mutoh Y, Nguyen D, Verweij E, Zoufaly A, Osinusi AO, DeZure A, Zhao Y, Zhong L, Chokkalingam A, Elboudwarej E, Telep L, Timbs L, Henne I, Sellers S, Cao H, Tan SK, Winterbourne L, Desai P, Mera R, Gaggar A, Myers RP, Brainard DM, Childs R, Flanigan T. Compassionate Use of Remdesivir for Patients with Severe Covid-19. The New England Journal of Medicine. 2020;382(24):2327-2336. https://doi.org/10.1056/NEJMoa2007016
Javorac D, Grahovac L, Manić L, Stojilković N, Anđelković M, Bulat Z, Đukić-Ćosić D, Curcic M, Djordjevic AB. An overview of the safety assessment of medicines currently used in the COVID-19 disease treatment. Food and Chemical Toxicology. 2020;144:111639. https://doi.org/10.1016/j.fct.2020.111639
Mazer M, Perrone J. Acetaminophen-induced nephrotoxicity: pathophysiology, clinical manifestations, and management. Journal of Medical Toxicology. 2008;4(1):2-6. https://doi.org/10.1007/BF03160941
Goldstein SL, Dahale D, Kirkendall ES, Mottes T, Kaplan H, Muething S, Askenazi DJ, Henderson T, Dill L, Somers MJG, Kerr J, Gilarde J, Zaritsky J, Bica V, Brophy PD, Misurac J, Hackbarth R, Steinke J, Mooney J, Ogrin S, Chadha V, Warady B, Ogden R, Hoebing W, Symons J, Yonekawa K, Menon S, Abrams L, Sutherland S, Weng P, Zhang F, Walsh K. A prospective multi-center quality improvement initiative (NINJA) indicates a reduction in nephrotoxic acute kidney injury in hospitalized children. Kidney International. 2020;97(3):580-588. https://doi.org/10.1016/j.kint.2019.10.015

Close metadata